37 results about "Prescribed drugs" patented technology

A system and method for prescription therapy management and compliance are provided. The system framework integrates primary databases from pharmacies, pharmacy benefit managers (PBMs), health plans, and EHR providers with a secondary database system, user interface, and wireless messaging platform, in order to extract and aggregate user-specific prescription data and make it available to users through a personalized account and as a part of a wireless prescription reminder service. The system helps users access, aggregate, manage, update, automate, and schedule the prescriptions they are currently taking. Users receive real-time wireless prescription dosing reminders based on their prescribed drug, dosage, and other indications, tailored to each individual's daily schedule. These wireless dosing reminders (i) include additional instructional content such as pill images, compliance tools, and Web or WAP drug links, (ii) are automatically scheduled and transmitted based on the user's prescription source data, in conjunction with selections indicated on their personal account, and (iii) are transmitted via SMS, EMS, MMS, WAP, email, and other formats to the user's mobile phone, PDA, or other wireless device. The integrated interface and secondary database system enable a number of additional system features which focus on compliance and management of the underlying source prescription data.

A system and method for improving compliance by a patient with a medical regimen that has been prescribed to the patient wherein utilizing computer and electronic communication systems, patient data is compared to pharmaceutical data to verify prescribed drug dosage and prescribed medication duration are within acceptable limits, any abnormalities found by the comparisons are reported to the treating physician who may then alter the medical regimen before authorizing dispensing of the prescribed drugs and providing drug taking information to the patient, and upon authorization being issued, the patient is scheduled to receive reminder notifications prior to the prescribed time for the prescribed drugs to be administered, as well as automatically notifying the prescription distribution service to deliver the prescribed drugs to the patient, and notifying the payor service to pay for the prescribed drugs.

A prescription creation software system implemented on a computer is provided. The prescription creation software system includes a prescription creation screen display to allow the data capture of information including, patient-identifying data, prescribed drug identification data and drug quantification data. The prescription creation software system additionally provides a prescriber with drug formulary information identifying at least one drug as a patient's drug formulary preference, prior to completion of the prescription.

A patient is diagnosed and a regimen of treatment is prescribed in a system which tests the patients, receives test results from a patient, including DNA test results. A database of human genome data correlating human health disorder with DNA genetic tests is accessed. A database of environmental factors which correlate known human health disorders with environmental conditions is accessed. Risk factors including genetic risk and environmental risk are developed, and from these, a composite risk factor is developed. This is used to access a database of prescribed drug therapy.

The present invention provides novel methods for monitoring subject adherence in taking prescribed drugs by detecting markers in exhaled breath after a subject takes the prescribed drug. In particular, the present invention provides novel methods for making additives that are combined with the drug(s). Upon biological breakdown of the drug / additive formulation in a subject's body, markers resulting directly from the biological breakdown of the additives are detected in exhaled breath using sensor technology. In certain embodiments of the invention, the drug adherence monitoring systems and methods include a reporting system capable of tracking subject compliance (either remotely or proximately) and of providing necessary alerts to the subject, caregiver, healthcare provider, and the like.

A system to electronically assist health care professionals quickly and efficiently calculate dosages and infusion rates for emergency drugs. The system comprises a portable hand-held calculator incorporating user input keys dedicated to commonly prescribed drugs, quick entry of default drug values, and toggles between at least two operational modes, specifically between adult and pediatric modes. In addition, the system alarms on the entry of “out-of-range” drug values, titrates, immediately ascertains compatibilities between drugs, and allows the updating of stored drug parameters by means of physical or wireless data ports.

Systems and methods may be provided for interactive virtual pharmacies. The systems and methods may include receiving, by a non-dispensing virtual pharmacy, an electronic prescription identifying at least a prescribed drug or product for a patient; obtaining, by the virtual pharmacy, a location preference of the patient; determining, by the virtual pharmacy, that the location preference of the patient indicates a current location associated with a patient mobile device; responsive to determining that the location preference indicates the current location, obtaining, by the virtual pharmacy, current location information of the mobile device; determining, by the virtual pharmacy, a plurality of dispensing pharmacies within proximity of the current location provided by the current location information, where the determined dispensing pharmacies are capable of filling the prescription for the patient; and delivering, in real-time from the virtual pharmacy to a mobile device, identification of at least a portion of the determined dispensing pharmacies to the mobile device.

This disclosure relates to drug delivery methods and related products. In some aspects, a method includes selecting a drug vial combination by comparing a prescribed drug dosage to a dosing schedule, and delivering substantially all of the first drug from each of the selected drug vials to a patient by operating a pump of a drug delivery device to which the drug vials are connected.

A technique for assuring patient use of the correct drug pill for a prescribed treatment of a particular body organ or part, involving shaping the pill to have an appearance resembling such body organ—in particular, appropriate prophylactic-dose aspirin pills of heart-shape, as well as other drug pills for treating other body parts the shape of which is imparted to the respective pills.

Systems and methods may be provided for supporting drug or product recalls. The systems and methods may include receiving a healthcare transaction request from a pharmacy computer associated with a pharmacy, wherein the healthcare transaction request includes an identification of a prescribed drug or product; determining, based upon the identification of the prescribed drug or product, that the prescribed drug or product is associated with a recall; providing, in response to the determination that the prescribed drug or product is associated with the recall, a response that includes information for accessing a web portal interface; receiving, over the web portal interface, lot numbers associated with pharmacy inventory of the prescribed drug or product; determining that one or more of the received lot numbers are affected by the recall; and generating a notification identifying the received lot numbers that are associated with the pharmacy inventory.

Systems and methods may be provided for interactive virtual pharmacies. The systems and methods may include receiving, by a non-dispensing virtual pharmacy comprising one or more computers, an electronic prescription associated with a patient, where the electronic prescription is associated with at least one drug or product prescribed for the patient; determining, by the virtual pharmacy, a respective total price payable to each of the plurality of dispensing pharmacies for filling the prescribed drug or product for the patient; determining, by the virtual pharmacy based upon the determined respective total prices, availability of a respective incentive or penalty for filling the prescription at one or more of the plurality of dispensing pharmacies; and delivering, in real-time from the virtual pharmacy to a patient device, a presentation of at least a portion of the plurality of dispensing pharmacies, where the presentation is based at least in part on the determined incentive or penalty for filling the prescription.

A system and method for monitoring and improving health conditions, by tracking patient compliance and activity levels. A medical device, particularly an oxygen concentrator, supplies a prescribed drug, particularly oxygen, to a user at prescribed time intervals throughout a prescribed exercise routine. An intermediary computing device tracks administration of the prescribed drug and relays the information to a back-end computing device, wherein the back-end computing device determines compliance with a medical prescription. A fitness tracker may optionally be utilized to monitors vitals of the user, wherein vitals data is relayed to the back-end computing device through the intermediary computing device. The back-end computing device can then use the vitals data to generate an adjusted medical prescription.

The invention teaches derivatives of mycophenolic alcohol and methods of preparing immunogens and other conjugates useful in immunoassays for quantitatively measuring concentrations of mycophenolic acid (MPA) and / or active metabolites of MPA in patient specimens. Antibodies produced from the disclosed immunogens capable of binding to MPA with cross-reactivity of no more than 5% with inactive metabolites and commonly co-prescribed drugs. Further, immunoassays for measuring the concentration of MPA using such antibodies are taught.

The present invention provides compositions and methods for synthesizing labeled drugs. The present invention further provides methods for preventing or stopping prescription drug abuse for all agents registered as a Drug Enforcement Agency (DEA) schedule II through schedule V medications. According to the present invention, methods are provided for monitoring patient compliance with prescribed drug treatment. The present invention also provides methods for facilitating a replacement prescription when a patient is left without access to their prescribed drug. Furthermore, the present invention provides a method to improve employee compliance with an employer's drug policies via either a voluntary or compulsory system for enhanced drug testing.

Provided are a method and computer system for facilitating a request for prior authorization of insurance coverage for a prescribed drug. An appropriate submission protocol is identified from among a plurality of different submission protocols available based on user input received over a communication network. Content is served to be utilized by a user computer for generating a user interface comprising a plurality of data-entry fields in which a user is to enter the patient-related information that is to be submitted as part of the request for prior authorization. The content transmitted is to be used for generating the user interface to include common fields regardless of which of the plurality of different submission protocols is to be utilized, thereby providing users with a transparent, familiar experience to submit a request for prior authorization according to different submission protocols.

The invention teaches derivatives of mycophenolic alcohol and methods of preparing immunogens and other conjugates useful in immunoassays for quantitatively measuring concentrations of mycophenolic acid (MPA) and / or active metabolites of MPA in patient specimens. Antibodies produced from the disclosed immunogens capable of binding to MPA with cross-reactivity of no more than 5% with inactive metabolites and commonly co-prescribed drugs. Further, immunoassays for measuring the concentration of MPA using such antibodies are taught.

An automatic drug dispensing and picking system that automatically dispenses prescribed drugs on the basis of prescription data includes a plurality of drug bottle storage racks storing a plurality of drug bottles, a traveling rail, a crane device, a drug bottle control device, a cap removing device, a drug picking device. The drug bottle is stored in the corresponding drug bottle storage rack with each drug bottle laid horizontally. The crane device includes a picking arm and pick the drug bottle from the corresponding one of the drug bottle storage racks. The drug bottle control device includes a drug bottle holding section, a sliding section capable of sliding the drug bottle holding section, a drug bottle turning section configured to turn the drug bottle holding section vertically at a predetermined angle, a drug bottle raising and lowering section configured to raise and lower the drug bottle holding section.

Provided are a method and computer system for facilitating a request for prior authorization of insurance coverage for a prescribed drug. An appropriate submission protocol is identified from among a plurality of different submission protocols available based on user input received over a communication network. Content is served to be utilized by a user computer for generating a user interface comprising a plurality of data-entry fields in which a user is to enter the patient-related information that is to be submitted as part of the request for prior authorization. The content transmitted is to be used for generating the user interface to include common fields regardless of which of the plurality of different submission protocols is to be utilized, thereby providing users with a transparent, familiar experience to submit a request for prior authorization according to different submission protocols.

Methods and systems for maintaining pharmacy provider networks are described. In one embodiment, claims adjudication data associated with a member and a prescribed drug is accessed. The prescribed drug associated with the member is classified as one of an acute medication and a maintenance medication. A pharmacy provider network is associated with the prescribed drug based on, at least in part, classifying the prescribed drug. It is determined if a pharmacy associated with the claims adjudication data is included within the pharmacy provider network associated with the prescribed drug. A pharmacy claim may be adjudicated for the prescribed drug based on the claim and the pharmacy provider network. Additional methods and systems are disclosed.

A main unit of an electronic chart apparatus is connected to a chart database, a medicament information database and a food information database through a LAN. The chart database contains chart data created based on medical records including a diagnosed injury or disease and drugs prescribed for this injury or disease. Based on the medical records on a patient, cautionary information on such foods that can give bad influence on the patient in relation to the diagnosed injury or disease is retrieved from the food information database, and also cautionary information on such foods that must be taken with caution about concomitant intake with the prescribed drugs is retrieved from the medicament information database. With reference to the results of retrieval, a dietary instruction is given to the patient, avoiding such foods that are indicated by the retrieved cautionary information.

Non-aqueous patches comprising lidocaine, which is not dissolved and is present in a crystalline state, have poor permeability to the skin. Therefore, non-aqueous patches have a high concentration of lidocaine. It is pointed out that lidocaine has an adverse effect on the heart. Prolonged use of a high concentration of lidocaine causes side effects, such as shock, rubor, and irritating sensation. External preparations comprising more than 5 mass % of lidocaine are designated as powerful drugs, and cannot be used as household (nonprescription) medicine. Provided is a non-aqueous patch that is effective to relieve muscle pain, the non-aqueous patch comprising lidocaine and / or its reactant, and a dissolving agent composed of an organic acid and a polyalcohol, which are contained in a base.

An automatic drug dispensing and picking system that automatically dispenses prescribed drugs on the basis of prescription data includes a plurality of drug bottle storage racks storing a plurality of drug bottles, a traveling rail, a crane device, a drug bottle control device, a cap removing device, a drug picking device. The drug bottle is stored in the corresponding drug bottle storage rack with each drug bottle laid horizontally. The crane device includes a picking arm and pick the drug bottle from the corresponding one of the drug bottle storage racks. The drug bottle control device includes a drug bottle holding section, a sliding section capable of sliding the drug bottle holding section, a drug bottle turning section configured to turn the drug bottle holding section vertically at a predetermined angle, a drug bottle raising and lowering section configured to raise and lower the drug bottle holding section.

The invention provides a multi-drug phased continuous controlled-release drug delivery system and a preparation method thereof. The system is spherical, takes sodium alginate hydrogel doped with polyglycolide-polyethylene glycol monomethyl ether block copolymer drug-carrying microspheres as a matrix material, adopts a multi-nozzle 3D printer to sequentially print a sodium alginate solution mixed with different drug-carrying microspheres from outside to inside in a radial direction according to a prescribed drug release sequence, and extruded materials are quickly crosslinked and shaped under the action of a calcium chloride solution. By controlling the molar ratio of lactide to glycolide in a drug-carrying matrix PLGA-mPEG and a molding position of the sodium alginate hydrogel doped with different drug-carrying microspheres, the phased continuous controlled release of multiple drugs can be achieved.

A method of data stratification is provided for management of a patient group according to individual risk factors. The method comprises the step of: a) receiving a patient data, wherein the patient data comprising: i. a unique identifier; ii. a first medication list comprising currently prescribed medications. The method further comprises the steps of: b) producing a drug data by comparing the first medication list with a drug risk classification database; c) determining a new risk value using the drug data and the patient data; d) inserting the patient data into a memory; and e) accessing the memory and ordering the unique identifiers into ordered unique identifiers, wherein the ordered unique identifiers being ordered according to the corresponding new risk values. The invention may in some embodiments generate new risk values according to a supervised machine learning model, which may include a neural network, and implemented using a machine learning module. The present method preferably provides improved management of a patient group wherein a number of potentially interacting risk factors are accommodated.

Methods and systems for maintaining pharmacy provider networks are described. In one embodiment, claims adjudication data associated with a member and a prescribed drug is accessed. The prescribed drug associated with the member is classified as one of an acute medication and a maintenance medication. A pharmacy provider network is associated with the prescribed drug based on, at least in part, classifying the prescribed drug. It is determined if a pharmacy associated with the claims adjudication data is included within the pharmacy provider network associated with the prescribed drug. A pharmacy claim may be adjudicated for the prescribed drug based on the claim and the pharmacy provider network. Additional methods and systems are disclosed.

Method, apparatus, and hospital information system for prompting medication safety. The method includes: extracting identifier information and execution time of a prescribed drug from a treatment information database; according to the identifier information of the drug, extracting a record related to the drug from an information database; for each contributor factor of the prescribed drug, determining an unsafe time interval corresponding to the contributor factor of the drug; extracting identifier information and execution time of a target factor from the treatment information database; and, in response to the target factor matching with a contributor factor of the drug and at least a part of the execution time of the target factor falling within the unsafe time interval corresponding to the matched contributor factor, prompting medication safety in the complete drug taking lifetime. Through adopting the present invention, internal data process can be optimized and medication safety can be improved.

A method for extracting a related disease from a patient prescription and providing extracted disease related information is provided. The method prioritizes a predefined primary disease name based on a medical department and a prescribed drug on a patient prescription, and additionally extracts one or more secondary disease names based on a predefined severity level thereof. In this connection, the disease related information is outputted based on a weight allocated thereto based on whether the extracted disease is the primary disease and based on the disease severity level thereof. Thus, when extracting the related disease based on the drug information on the patient prescription, the primary disease is prevented from being excluded from the output. Further, the disease-related information is output based on the predefined diseases severity level.

Methods and systems for maintaining pharmacy provider networks are described. In one embodiment, claims adjudication data associated with a member and a prescribed drug is accessed. The prescribed drug associated with the member is classified as one of an acute medication and a maintenance medication. A pharmacy provider network is associated with the prescribed drug based on, at least in part, classifying the prescribed drug. It is determined if a pharmacy associated with the claims adjudication data is included within the pharmacy provider network associated with the prescribed drug. A pharmacy claim may be adjudicated for the prescribed drug based on the claim and the pharmacy provider network. Additional methods and systems are disclosed.